Search results for “Glucagon-like peptide 1 receptor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 192 patents, we discovered top 40 key players by total patent application. Sanofi SA, Hanmi Science Co., Ltd., vTv Therapeutics LLC are dominant in this area. They take 50.52% of the total patent filing.
France
Patent: 66
South Korea
Patent: 18
North Carolina, United States
Patent: 13
South Korea
Patent: 10
Guangdong Sheng, China
Patent: 10
Indiana, United States
Patent: 9
California, United States
Patent: 8
New York, United States
Patent: 7
United States
Patent: 5
STARTUP
South Korea
Patent: 4
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 6 patents, we discovered top 3 start-ups by total patent application.
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 23 patents applied in the last 5 years. We discover 13 most active companies in this area. The fast-growing Sanofi SA, Sun Yat-Sen University, Shenzhen Turier Biotech Co. Ltd. take 43.48% of patent filing during this period.
France
Patent: 4
Guangdong Sheng, China
Patent: 3
Guangdong Sheng, China
Patent: 3
New York, United States
Patent: 2
Tennessee, United States
Patent: 2
New York, United States
Patent: 2
STARTUP
Neuraly, Inc.
United States
Patent: 1
STARTUP
Beijing Shi, China
Patent: 1
South Korea
Patent: 1
North Carolina, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 23 patents in last 5 years, we discover 5 new entrants. Vanderbilt University, Regeneron Pharmaceuticals, Inc., Neuraly, Inc. are the most active new entrants in this area.
Tennessee, United States
Patent: 2
New York, United States
Patent: 2
STARTUP
Neuraly, Inc.
United States
Patent: 1
STARTUP
Beijing Shi, China
Patent: 1
California, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 62 patents, we discovered top 9 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, The Scripps Research Institute, Sun Yat-Sen University are dominant in this area. They take 62.90% of the total patent filing.
Shanghai Shi, China
Patent: 26
California, United States
Patent: 5
Guangdong Sheng, China
Patent: 4
New York, United States
Patent: 4
Asturias, Spain
Patent: 4
Tennessee, United States
Patent: 2
Yunnan Sheng, China
Patent: 2
Jiangsu Sheng, China
Patent: 1
Shanghai Shi, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: